Published • loading... • Updated
Lexitas Pharma Services Named Octane Preferred Advisor
Summary by Eyewire+
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Lexitas Pharma Services Named Octane Preferred Advisor
Lexitas Pharma Services has been named the newest Octane Preferred Advisor (OPA), expanding the resources available to founders, startups, and growth-stage companies developing ophthalmic drugs and devices within Octane’s innovation ecosystem. According to the companies, the partnership brings together Octane’s network-building and growth support capabilities with Lexitas’ specialized ophthalmology clinical development expertise. As a full-servi…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
